Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

ClinicalTrials.gov ID: NCT04462536

Public ClinicalTrials.gov record NCT04462536. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 5:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to determine if a single dose of nerinetide can reduce global disability in people who have had a stroke and are selected for endovascular therapy without the use of a tissue plasminogen activator (alteplase, tenecteplase, or equivalent).

Study identification

NCT ID
NCT04462536
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NoNO Inc.
Industry
Enrollment
850 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 6, 2020 (Actual)
Primary completion
Aug 31, 2023 (Actual)
Completion
Aug 31, 2023 (Actual)
Last update posted
Jun 22, 2025

2020 – 2023

United States locations

U.S. sites
17
U.S. states
14
U.S. cities
17
Facility City State ZIP Site status
St. Joseph's Hospital & Medical Center Phoenix Arizona 85013 —
Providence Little Company of Mary Medical Center - Torrance Torrance California 90503 —
Swedish Medical Center Englewood Colorado 80113 —
Baptist Health Research Institute Jacksonville Florida 32207 —
University of Miami, Jackson Memorial Hospital Miami Florida 33136 —
Grady Memorial Hospital Atlanta Georgia 30303 —
University of Maryland Medical Center Baltimore Maryland 21201 —
University of Massachusetts Medical School Worcester Massachusetts 01655 —
NYU Langone Hospital Brooklyn Brooklyn New York 11220 —
Montefiore Medical Center The Bronx New York 10467 —
The Ohio State University, Wexner Medical Center Neurological Surgery Columbus Ohio 43203 —
Providence St. Vincent Medical Center Portland Oregon 97225 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
UPMC Stroke Institute Pittsburgh Pennsylvania 15213 —
Rhode Island Hospital Providence Rhode Island 02903-4923 —
Valley Baptist Medical Center - Harlingen Harlingen Texas 78550 —
Swedish Medical Center - Cherry Hill Campus Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04462536, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2025 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04462536 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →